129 related articles for article (PubMed ID: 35656940)
1. Impact of minor bleeds on confidence in anticoagulation therapy, adherence to treatment and quality of life in patients using a non-vitamin K antagonist oral anticoagulant for atrial fibrillation.
Mitrovic D; Veeger N; van Roon E
Curr Med Res Opin; 2022 Sep; 38(9):1485-1488. PubMed ID: 35656940
[TBL] [Abstract][Full Text] [Related]
2. Costs of minor bleeds in atrial fibrillation patients using a non-vitamin K antagonist oral anticoagulant.
Mitrovic D; Plomp M; Folkeringa R; Veeger N; Feenstra T; van Roon E
Curr Med Res Opin; 2021 Sep; 37(9):1461-1466. PubMed ID: 33989088
[TBL] [Abstract][Full Text] [Related]
3. Minor bleeding in patients with atrial fibrillation using a non-vitamin-K antagonist oral anticoagulant.
Mitrovic D; Folkeringa R; Veeger N; van Roon E
Curr Med Res Opin; 2020 Oct; 36(10):1571-1576. PubMed ID: 32573287
[TBL] [Abstract][Full Text] [Related]
4. Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study.
Forslund T; Wettermark B; Andersen M; Hjemdahl P
Europace; 2018 Mar; 20(3):420-428. PubMed ID: 28177459
[TBL] [Abstract][Full Text] [Related]
5. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP;
Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354
[TBL] [Abstract][Full Text] [Related]
6. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P
Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115
[TBL] [Abstract][Full Text] [Related]
7. The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients.
Kim D; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Sung JH; Pak HN; Lee MH; Lip GYH; Joung B
Europace; 2020 Apr; 22(4):547-557. PubMed ID: 31598651
[TBL] [Abstract][Full Text] [Related]
8. Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.
Lee MY; Han S; Bang OY; On YK; Jang SW; Han S; Ryu J; Park YJ; Kang S; Suh HS; Kim YH
Adv Ther; 2022 Jul; 39(7):3112-3130. PubMed ID: 35524839
[TBL] [Abstract][Full Text] [Related]
9. Community pharmacy-based study of adherence to non-vitamin K antagonist oral anticoagulants.
Capiau A; Mehuys E; Van Tongelen I; Christiaens T; De Sutter A; Steurbaut S; Moudallel S; Rydant S; Vrijens B; de Backer TLM; Boussery K
Heart; 2020 Nov; 106(22):1740-1746. PubMed ID: 32576607
[TBL] [Abstract][Full Text] [Related]
10. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group.
Pharithi RB; Ranganathan D; O'Brien J; Egom EE; Burke C; Ryan D; McAuliffe C; Vaughan M; Coughlan T; Morrissey E; McHugh J; Moore D; Collins R
Ir J Med Sci; 2019 Feb; 188(1):101-108. PubMed ID: 29860595
[TBL] [Abstract][Full Text] [Related]
11. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
Steffel J; Verhamme P; Potpara TS; Albaladejo P; Antz M; Desteghe L; Haeusler KG; Oldgren J; Reinecke H; Roldan-Schilling V; Rowell N; Sinnaeve P; Collins R; Camm AJ; Heidbüchel H;
Eur Heart J; 2018 Apr; 39(16):1330-1393. PubMed ID: 29562325
[TBL] [Abstract][Full Text] [Related]
12. Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study.
Emren SV; Zoghi M; Berilgen R; Özdemir İH; Çelik O; Çetin N; Enhoş A; Köseoğlu C; Akyüz A; Doğan V; Levent F; Dereli Y; Doğan T; Başaran Ö; Karaca I; Karaca Ö; Otlu YÖ; Özmen Ç; Coşar S; Sümerkan M; Gürsul E; İnci S; Onrat E; Ergene O
Bosn J Basic Med Sci; 2018 May; 18(2):185-190. PubMed ID: 28968197
[TBL] [Abstract][Full Text] [Related]
13. Utilization of oral anticoagulants in Korean nonvalvular atrial fibrillation patients.
Song HY; Son KB; Shin JY; Bae S
Int J Clin Pharm; 2019 Dec; 41(6):1434-1441. PubMed ID: 31522377
[TBL] [Abstract][Full Text] [Related]
14. Label Adherence for Non-Vitamin K Antagonist Oral Anticoagulants in a Prospective Cohort of Asian Patients with Atrial Fibrillation.
Lee SR; Lee YS; Park JS; Cha MJ; Kim TH; Park J; Park JK; Lee JM; Kang KW; Shim J; Uhm JS; Kim J; Kim C; Kim JB; Park HW; Joung B; Choi EK
Yonsei Med J; 2019 Mar; 60(3):277-284. PubMed ID: 30799590
[TBL] [Abstract][Full Text] [Related]
15. Treatment Changes among Users of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation.
Hellfritzsch M; Husted SE; Grove EL; Rasmussen L; Poulsen BK; Johnsen SP; Hallas J; Pottegård A
Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):187-194. PubMed ID: 27580086
[TBL] [Abstract][Full Text] [Related]
16. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary.
Steffel J; Verhamme P; Potpara TS; Albaladejo P; Antz M; Desteghe L; Georg Haeusler K; Oldgren J; Reinecke H; Roldan-Schilling V; Rowell N; Sinnaeve P; Collins R; Camm AJ; Heidbüchel H;
Europace; 2018 Aug; 20(8):1231-1242. PubMed ID: 29562331
[TBL] [Abstract][Full Text] [Related]
17. Minor bleeding affects the level of knowledge in patients with atrial fibrillation on oral anticoagulant therapy.
Metzgier-Gumiela A; Skonieczny G; Konieczyńska M; Desteghe L; Heidbuchel H; Undas A
Int J Clin Pract; 2020 Jun; 74(6):e13483. PubMed ID: 32003070
[TBL] [Abstract][Full Text] [Related]
18. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.
Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
Europace; 2015 Oct; 17(10):1467-507. PubMed ID: 26324838
[TBL] [Abstract][Full Text] [Related]
19. Clinical events preceding switching and discontinuation of oral anticoagulant treatment in patients with atrial fibrillation.
Hellfritzsch M; Grove EL; Husted SE; Rasmussen L; Poulsen BK; Johnsen SP; Hallas J; Pottegård A
Europace; 2017 Jul; 19(7):1091-1095. PubMed ID: 28641379
[TBL] [Abstract][Full Text] [Related]
20. Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study.
Moreno-Arribas J; Bertomeu-González V; Anguita-Sanchez M; Cequier Á; Muñiz J; Castillo J; Sanchis J; Roldán I; Marín F; Bertomeu-Martínez V;
J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):150-6. PubMed ID: 26229096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
